| scholarly article | Q13442814 |
| P50 | author | Soo Jin Yang | Q42706459 |
| P2093 | author name string | H B IglayReger | |
| H C Kadouh | |||
| P F Bodary | |||
| P2860 | cites work | Inflammation and insulin resistance | Q22241893 |
| Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 | ||
| Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
| Free fatty acids and insulin resistance | Q28287167 | ||
| MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity | Q29614283 | ||
| Adipocytokines: mediators linking adipose tissue, inflammation and immunity | Q29619393 | ||
| CCR2 modulates inflammatory and metabolic effects of high-fat feeding | Q29622869 | ||
| Blockade of CCR2 ameliorates progressive fibrosis in kidney. | Q35102859 | ||
| Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference | Q35115696 | ||
| Life without white fat: a transgenic mouse | Q35210661 | ||
| Adipose tissue, adipokines, and inflammation | Q36114223 | ||
| The fatty liver and insulin resistance | Q36126652 | ||
| Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. | Q36283799 | ||
| Non-alcoholic fatty liver disease and the metabolic syndrome: an update | Q37054351 | ||
| Generalized lipodystrophy, congenital and acquired (lipoatrophy). | Q41092401 | ||
| Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors | Q41208203 | ||
| Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. | Q43489113 | ||
| The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study | Q43748961 | ||
| Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse | Q43974826 | ||
| The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women | Q44067750 | ||
| Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins | Q44181135 | ||
| Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver | Q45232017 | ||
| Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice. | Q46345972 | ||
| Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis | Q46455735 | ||
| Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver | Q46818626 | ||
| Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters | Q46988914 | ||
| The significance of tumor necrosis factor-alpha in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment | Q51141324 | ||
| Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity | Q51467955 | ||
| Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects | Q53533679 | ||
| Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. | Q53556065 | ||
| A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects | Q53847918 | ||
| Lipoatrophy, lipodystrophy, and insulin resistance | Q54041787 | ||
| Effects of female sex hormones on mitochondria: possible role in acute fatty liver of pregnancy | Q72491890 | ||
| Mechanism of insulin resistance in A-ZIP/F-1 fatless mice | Q73561042 | ||
| CCR2 signaling contributes to ischemia-reperfusion injury in kidney | Q79091407 | ||
| Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy | Q80613413 | ||
| Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 | Q83161496 | ||
| P433 | issue | 5 | |
| P921 | main subject | hyperglycemia | Q271993 |
| steatosis | Q1365091 | ||
| P304 | page(s) | 972-981 | |
| P577 | publication date | 2009-03-10 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy | |
| P478 | volume | 52 |
| Q35404963 | Aberrant accumulation of undifferentiated myeloid cells in the adipose tissue of CCR2-deficient mice delays improvements in insulin sensitivity. |
| Q34804886 | Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance |
| Q33750735 | C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis |
| Q50116449 | CC Chemokine Receptor 2 Promotes Recruitment of Myeloid Cells Associated with Insulin Resistance in Non-Alcoholic Fatty Liver Disease |
| Q33816616 | CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice |
| Q37045180 | CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection. |
| Q47373037 | CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis |
| Q34655483 | Chemokine (C-C motif) Ligand 2 is a potential biomarker of inflammation & physical fitness in obese children: a cross-sectional study |
| Q37583987 | Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation? |
| Q84596471 | Current literature in diabetes |
| Q52900804 | Dietary Saturated Fat Promotes Development of Hepatic Inflammation Through Toll-Like Receptor 4 in Mice |
| Q60046358 | Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease |
| Q28074455 | How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease? |
| Q37101083 | Hyperglycemia induces altered expressions of angiogenesis associated molecules in the trophoblast |
| Q44083134 | Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial |
| Q103028799 | Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy |
| Q54483243 | Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice |
| Q43049709 | Newly identified adipose tissue macrophage populations in obesity with distinct chemokine and chemokine receptor expression. |
| Q37861765 | Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments |
| Q34042924 | Novel regulation of CCL2 gene expression by murine LITAF and STAT6B. |
| Q37080182 | Recent Advances in Obesity-Induced Inflammation and Insulin Resistance |
| Q26830328 | Role of cytokines and chemokines in non-alcoholic fatty liver disease |
| Q39179908 | Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis |
| Q42580307 | Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease |
| Q30408713 | The macrophage at the intersection of immunity and metabolism in obesity |
| Q38197441 | The role of chemokines in hepatitis C virus-mediated liver disease |
| Q93350798 | The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
| Q37960533 | Therapeutic potential of chemokine receptor antagonists for liver disease |
| Q39313206 | p53 is an important regulator of CCL2 gene expression |
| Q38930310 | p53 suppresses CCL2-induced subcutaneous tumor xenograft |
Search more.